+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • May 2024
  • GlobalData
  • ID: 1314934
Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Faes Farma SA (Faes Farma) develops, manufactures, and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over the counter (OTC) medications, baby foods, skin-care treatment products. It exports raw materials and finished pharmaceutical products to pharmaceutical companies worldwide. Faes Farma also owns animal nutrition and healthcare company such as Ingaso farm. The company operates manufacturing and R&D center in Leioa, Spain, laboratory, production plants, subsidiaries, and commercial offices in international markets. The company markets the products in Latin America, Asia, Europe, Africa, and the Middle East. Faes Farma is headquartered in Leioa, Spain.

Faes Farma SA Key Recent Developments

  • May 02, 2024: Faes Farma Proposes to Appoint Eduardo Recoder de la Cuadra as its New CEO
  • Apr 26, 2024: Faes Farma Increases its Net Profit by 10% in the First Quarter, up to 30.4 Million Euros
  • Feb 20, 2024: Faes Farma Reaches a Record Net Profit of 92 Million Euros, 2.5% More Than in 2022
  • Feb 20, 2024: We Present Our New Website. A Renewed Portal for an Era of Health and Sustainability

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Faes Farma SA - Key Facts
  • Faes Farma SA - Key Employees
  • Faes Farma SA - Major Products and Services
  • Faes Farma SA - History
  • Faes Farma SA - Company Statement
  • Faes Farma SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Faes Farma SA - Business Description
  • Business Segment: Animal Nutrition and Health
  • Overview
  • Performance
  • Business Segment: Pharmaceutical and Healthcare Specialties
  • Overview
  • Performance
  • Business Segment: Pharmaceutical Raw Materials
  • Overview
  • Performance
  • R&D Overview
  • Faes Farma SA - Corporate Strategy
  • Faes Farma SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Faes Farma SA - Strengths
  • Faes Farma SA - Weaknesses
  • Faes Farma SA - Opportunities
  • Faes Farma SA - Threats
  • Faes Farma SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Faes Farma SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 02, 2024: Faes Farma Proposes to Appoint Eduardo Recoder de la Cuadra as its New CEO
  • Apr 26, 2024: Faes Farma Increases its Net Profit by 10% in the First Quarter, up to 30.4 Million Euros
  • Feb 20, 2024: Faes Farma Reaches a Record Net Profit of 92 Million Euros, 2.5% More Than in 2022
  • Feb 20, 2024: We Present Our New Website. A Renewed Portal for an Era of Health and Sustainability
  • Oct 25, 2023: Faes Farma Reaches a Net Profit of 74 Million Euros in the First Nine Months of 2023
  • Jul 28, 2023: Faes Farma Achieves a Net Profit of 53 Million Euros in the First Half of the Year
  • Apr 26, 2023: Faes Farma Increases Its Net Profit by 4% in the First Quarter, Reaching 27.6 Million Euros
  • Apr 19, 2023: Faes Farma : HANTURA Project
  • Mar 14, 2023: Development of new diagnostic devices and immunomodulatory drugs based on 25(OH)D and VDR receptor agonists for the treatment of vitamin D deficiency and associated pathologies
  • Feb 28, 2023: Faes Farma achieves a consolidated profit of 89.5 million euros, 8.6% more than in 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Faes Farma SA, Key Facts
  • Faes Farma SA, Key Employees
  • Faes Farma SA, Major Products and Services
  • Faes Farma SA, History
  • Faes Farma SA, Subsidiaries
  • Faes Farma SA, Key Competitors
  • Faes Farma SA, Ratios based on current share price
  • Faes Farma SA, Annual Ratios
  • Faes Farma SA, Interim Ratios
  • Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Faes Farma SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Faes Farma SA, Performance Chart (2019 - 2023)
  • Faes Farma SA, Ratio Charts
  • Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Vifor Pharma Management Ltd
  • Laboratorios Richmond SACIF
  • Grifols SA
  • Almirall SA
  • Laboratorios Farmaceuticos Rovi SA
  • Corporacion Dermoestetica SA